$ORIG Investee TripSitter Trading on CSE Origin Therapeutics’ (soon to IPO under the ticker $ORIG) portfolio company TripSitter commenced trading on the CSE late November.
Tripsitter has seen tremendous growth in the past year, and this public listing is an exciting opportunity for the company to continue to fuel its trajectory. Tripsitter is a consultative virtual clinic and telehealth platform that connects prospective patients to a licensed physician in the United States who can evaluate for a prescribed treatment program of low-dose, oral ketamine medication.
The therapeutic psychedelics industry has me quite intrigued as it seems to me to be one of the most promising cutting edge approaches to the treatment of mental health currently. With TripSitter working towards harnessing the strengths of telemedicine into this industry the growth opportunity for the company seems exponential.
Looking forward to watching $ORIG’s performance once they go public, as the industry is ripe to see growth once regulations on psychedelics are lifted for use as widespread clinical treatments.
https://finance.yahoo.com/news/origin-therapeutics-portfolio-company-tripsitter-120000288.html